Vilacto Bio offering natural alternatives to strong drugs in the Psoriasis and diabetics market
April 09, 2019 09:00 ET
|
Vilacto Bio, Inc.
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB: VIBI) is happy to announce that the company has decided to introduce 2 new products and present them for the...
Vilacto Bio Canada Patent LACTOACTIVE® Granted
March 15, 2019 09:00 ET
|
Vilacto Bio, Inc.
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its...
Vilacto Bio Secured Patent Applications for LACTOACTIVE®
November 30, 2018 08:30 ET
|
Vilacto Bio, Inc.
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong....
Vilacto Bio Announces Launch of Carmen Electra by Vilact®
October 01, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact, based on the company’s LACTOACTIVE® compound. ...
Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER®
September 21, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound. LACTOACTIVE iTHER®...
Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound
September 10, 2018 15:50 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its LACTOACTIVE iTHER® product. LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines...
Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER®
July 11, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE iTHER®, as another potential revenue stream for the...
Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS
June 14, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM Skin, Bath, Cosmetics & Natural Beauty...
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody Production
May 23, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, May 23, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has completed a two-month upgrade to the Denmark production facility, which is owned by Pharma GP, that produces...
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center
January 18, 2018 08:30 ET
|
Vilacto Bio, Inc.
COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the Vilacto Bio Skincare Knowledge Center, an online...